Amalgamated Bank’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Sell
1
-411
-100% ﹤0.01% 3092
2025
Q1
$4K Hold
412
﹤0.01% 2728
2024
Q4
$6K Hold
412
﹤0.01% 2677
2024
Q3
$8K Hold
412
﹤0.01% 2565
2024
Q2
$8K Buy
+412
New +$8K ﹤0.01% 2566
2023
Q2
Sell
-4,926
Closed -$52K 3090
2023
Q1
$52K Sell
4,926
-313
-6% -$3.3K ﹤0.01% 2294
2022
Q4
$178K Sell
5,239
-304
-5% -$10.3K ﹤0.01% 1904
2022
Q3
$266K Buy
5,543
+194
+4% +$9.31K ﹤0.01% 1733
2022
Q2
$305K Sell
5,349
-284
-5% -$16.2K ﹤0.01% 1694
2022
Q1
$455K Buy
5,633
+1,684
+43% +$136K ﹤0.01% 1588
2021
Q4
$800K Sell
3,949
-4,695
-54% -$951K 0.01% 1348
2021
Q3
$2.33M Sell
8,644
-859
-9% -$231K 0.02% 858
2021
Q2
$2.45M Buy
9,503
+8,057
+557% +$2.07M 0.02% 876
2021
Q1
$434K Sell
1,446
-95
-6% -$28.5K 0.02% 1060
2020
Q4
$393K Buy
1,541
+6
+0.4% +$1.53K 0.01% 1088
2020
Q3
$382K Sell
1,535
-8
-0.5% -$1.99K 0.02% 990
2020
Q2
$536K Sell
1,543
-1,054
-41% -$366K 0.02% 796
2020
Q1
$695K Sell
2,597
-44
-2% -$11.8K 0.02% 758
2019
Q4
$855K Buy
2,641
+177
+7% +$57.3K 0.02% 875
2019
Q3
$673K Buy
2,464
+33
+1% +$9.01K 0.01% 912
2019
Q2
$1.3M Buy
2,431
+864
+55% +$461K 0.03% 639
2019
Q1
$790K Buy
1,567
+31
+2% +$15.6K 0.02% 803
2018
Q4
$757K Sell
1,536
-42
-3% -$20.7K 0.02% 761
2018
Q3
$1.44M Sell
1,578
-50
-3% -$45.7K 0.04% 502
2018
Q2
$1.19M Buy
1,628
+121
+8% +$88.7K 0.03% 671
2018
Q1
$2.4M Buy
1,507
+55
+4% +$87.7K 0.06% 303
2017
Q4
$1.3M Buy
1,452
+87
+6% +$77.9K 0.04% 589
2017
Q3
$491K Sell
1,365
-6
-0.4% -$2.16K 0.02% 952
2017
Q2
$402K Buy
1,371
+110
+9% +$32.3K 0.01% 1045
2017
Q1
$444K Sell
1,261
-2
-0.2% -$704 0.02% 904
2016
Q4
$232K Buy
1,263
+262
+26% +$48.1K 0.01% 1303
2016
Q3
$258K Hold
1,001
0.02% 1111
2016
Q2
$258K Buy
1,001
+78
+8% +$20.1K 0.01% 1109
2016
Q1
$190K Buy
923
+82
+10% +$16.9K 0.02% 1162
2015
Q4
$213K Sell
841
-82
-9% -$20.8K 0.03% 1024
2015
Q3
$152K Buy
923
+16
+2% +$2.64K 0.02% 1201
2015
Q2
$170K Buy
+907
New +$170K 0.02% 1266